应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
INSM Insmed
盘后交易 05-01 18:48:17 EDT
72.64
+0.64
+0.89%
盘后
71.51
-1.13
-1.56%
18:11 EDT
最高
73.31
最低
70.84
成交量
179.30万
今开
72.09
昨收
72.00
日振幅
3.43%
总市值
132.07亿
流通市值
121.48亿
总股本
1.82亿
成交额
1.30亿
换手率
1.07%
流通股本
1.67亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Insmed Incorporated4月30日成交额为1.07亿美元
市场透视 · 01:46
Insmed Incorporated4月30日成交额为1.07亿美元
Insmed Incorporated4月29日成交额为1.31亿美元
市场透视 · 04-30 01:45
Insmed Incorporated4月29日成交额为1.31亿美元
Insmed Incorporated4月28日成交额为1.80亿美元
市场透视 · 04-29 01:45
Insmed Incorporated4月28日成交额为1.80亿美元
Insmed Incorporated4月25日成交额为9.44亿美元
市场透视 · 04-26
Insmed Incorporated4月25日成交额为9.44亿美元
Insmed Incorporated4月24日成交额为2.47亿美元
市场透视 · 04-25
Insmed Incorporated4月24日成交额为2.47亿美元
Insmed Incorporated4月23日成交额为1.06亿美元
市场透视 · 04-24
Insmed Incorporated4月23日成交额为1.06亿美元
Insmed Incorporated4月21日成交额为1.41亿美元
市场透视 · 04-22
Insmed Incorporated4月21日成交额为1.41亿美元
Insmed Incorporated盘中异动 大幅跳水5.00%
市场透视 · 04-21
Insmed Incorporated盘中异动 大幅跳水5.00%
Insmed Incorporated4月17日成交额为1.08亿美元
市场透视 · 04-18
Insmed Incorporated4月17日成交额为1.08亿美元
Insmed Incorporated4月16日成交额为1.07亿美元
市场透视 · 04-17
Insmed Incorporated4月16日成交额为1.07亿美元
Insmed Incorporated4月14日成交额为1.68亿美元
市场透视 · 04-15
Insmed Incorporated4月14日成交额为1.68亿美元
Insmed Incorporated4月11日成交额为1.23亿美元
市场透视 · 04-12
Insmed Incorporated4月11日成交额为1.23亿美元
Insmed(INSM.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价100.00美元。
金融界 · 02-25
Insmed(INSM.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价100.00美元。
Insmed Incorporated2024财年实现净利润-9.14亿美元,同比减少21.87%
市场透视 · 02-23
Insmed Incorporated2024财年实现净利润-9.14亿美元,同比减少21.87%
Truist Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由105.00美元调整至108.00美元。
金融界 · 02-21
Truist Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由105.00美元调整至108.00美元。
异动解读 | 盘中狂泻5.11%!Insmed财报营收增长放缓、亏损扩大引发股价大跌
异动解读 · 02-20
异动解读 | 盘中狂泻5.11%!Insmed财报营收增长放缓、亏损扩大引发股价大跌
Insmed 2024年第四季度每股亏损$(1.32),低于$(1.17)的预期;销售额$1.0444亿,高于$1.0179亿的预期
财报速递 · 02-20
Insmed 2024年第四季度每股亏损$(1.32),低于$(1.17)的预期;销售额$1.0444亿,高于$1.0179亿的预期
小摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由83.00美元调整至92.00美元。
金融界 · 02-07
小摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由83.00美元调整至92.00美元。
大摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由85.00美元调整至90.00美元。
金融界 · 02-06
大摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由85.00美元调整至90.00美元。
Insmed Incorporated盘中异动 股价大涨5.09%
市场透视 · 01-21
Insmed Incorporated盘中异动 股价大涨5.09%
公司概况
公司名称:
Insmed
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。
发行价格:
--
{"stockData":{"symbol":"INSM","market":"US","secType":"STK","nameCN":"Insmed","latestPrice":72.64,"timestamp":1746129600000,"preClose":72,"halted":0,"volume":1792977,"hourTrading":{"tag":"盘后","latestPrice":71.51,"preClose":72.64,"latestTime":"18:11 EDT","volume":43818,"amount":3182865.0294,"timestamp":1746137468433},"delay":0,"floatShares":167232172,"shares":181820010,"eps":-5.570319,"marketStatus":"盘后交易","change":0.64,"latestTime":"05-01 18:48:17 EDT","open":72.09,"high":73.31,"low":70.84,"amount":130017440.27868001,"amplitude":0.034306,"askPrice":74,"askSize":30,"bidPrice":65.39,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.570319,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":959832000000,"exchange":"NASDAQ","adjPreClose":72,"preHourTrading":{"tag":"盘前","latestPrice":72.81,"preClose":72,"latestTime":"09:28 EDT","volume":19,"amount":1373.7399,"timestamp":1746106080036},"postHourTrading":{"tag":"盘后","latestPrice":71.51,"preClose":72.64,"latestTime":"18:11 EDT","volume":43818,"amount":3182865.0294,"timestamp":1746137468433},"volumeRatio":0.387993,"impliedVol":0.6901,"impliedVolPercentile":0.84},"requestUrl":"/m/hq/s/INSM/wiki","defaultTab":"wiki","newsList":[{"id":"2532017640","title":"Insmed Incorporated4月30日成交额为1.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532017640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532017640?lang=zh_cn&edition=full","pubTime":"2025-05-01 09:46","pubTimestamp":1746064000,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日,Insmed Incorporated成交额为1.07亿美元,成交额较昨日减少18.47%,当日成交量为149.30万股。Insmed Incorporated于2025年4月30日涨0.84%,报72.0美元,该股过去5个交易日涨1.69%,年初至今涨4.29%,过去60日跌7.55%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-30|1.07亿|-18.47%|149.30万|#|2025-04-29|1.31亿|-27.11%|184.66万|#|2025-04-28|1.80亿|-80.90%|258.09万|#|2025-04-25|9.44亿|282.47%|1361.08万|#|2025-04-24|2.47亿|132.62%|357.45万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501094651a6cf89fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501094651a6cf89fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","INSM","BK4139","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2531262497","title":"Insmed Incorporated4月29日成交额为1.31亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531262497","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531262497?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:45","pubTimestamp":1745977523,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日,Insmed Incorporated成交额为1.31亿美元,成交额较昨日减少27.11%,当日成交量为184.66万股。Insmed Incorporated于2025年4月29日涨2.2%,报71.4美元,该股过去5个交易日涨0.22%,年初至今涨3.42%,过去60日跌6.76%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430094534a6ce1cba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430094534a6ce1cba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4139","INSM","LU0320765992.SGD","LU0053671581.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2531721138","title":"Insmed Incorporated4月28日成交额为1.80亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531721138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531721138?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:45","pubTimestamp":1745891102,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日,Insmed Incorporated成交额为1.80亿美元,成交额较昨日减少80.90%,当日成交量为258.09万股。Insmed Incorporated于2025年4月28日涨0.24%,报69.86美元,该股过去5个交易日涨0.5%,年初至今涨1.19%,过去60日跌8.43%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-28|1.80亿|-80.90%|258.09万|#|2025-04-25|9.44亿|282.47%|1361.08万|#|2025-04-24|2.47亿|132.62%|357.45万|#|2025-04-23|1.06亿|-4.13%|148.63万|#|2025-04-22|1.11亿|-21.47%|155.43万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429094512a46b46c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429094512a46b46c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","INSM","LU0889565916.HKD","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2530115124","title":"Insmed Incorporated4月25日成交额为9.44亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530115124","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530115124?lang=zh_cn&edition=full","pubTime":"2025-04-26 09:44","pubTimestamp":1745631881,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日,Insmed Incorporated成交额为9.44亿美元,成交额较昨日增加282.47%,当日成交量为1361.08万股。Insmed Incorporated于2025年4月25日涨1.06%,报69.69美元,该股过去5个交易日跌4.07%,年初至今涨0.94%,过去60日跌10.65%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-25|9.44亿|282.47%|1361.08万|#|2025-04-24|2.47亿|132.62%|357.45万|#|2025-04-23|1.06亿|-4.13%|148.63万|#|2025-04-22|1.11亿|-21.47%|155.43万|#|2025-04-21|1.41亿|30.59%|202.65万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426094450a4678b44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426094450a4678b44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0053671581.USD","LU0889565916.HKD","LU0109394709.USD","BK4139","INSM"],"gpt_icon":0},{"id":"2530691713","title":"Insmed Incorporated4月24日成交额为2.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530691713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530691713?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:43","pubTimestamp":1745545426,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日,Insmed Incorporated成交额为2.47亿美元,成交额较昨日增加132.62%,当日成交量为357.45万股。Insmed Incorporated于2025年4月24日跌2.6%,报68.96美元,该股过去5个交易日跌1.77%,年初至今跌0.12%,过去60日跌12.11%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-24|2.47亿|132.62%|357.45万|#|2025-04-23|1.06亿|-4.13%|148.63万|#|2025-04-22|1.11亿|-21.47%|155.43万|#|2025-04-21|1.41亿|30.59%|202.65万|#|2025-04-17|1.08亿|0.64%|150.11万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425094354a6c75e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425094354a6c75e4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","LU0889565916.HKD","INSM","LU0109394709.USD","LU0053671581.USD"],"gpt_icon":0},{"id":"2529168216","title":"Insmed Incorporated4月23日成交额为1.06亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529168216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529168216?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:42","pubTimestamp":1745458956,"startTime":"0","endTime":"0","summary":"美东时间2025年4月23日,Insmed Incorporated成交额为1.06亿美元,成交额较昨日减少4.13%,当日成交量为148.63万股。Insmed Incorporated于2025年4月23日跌0.62%,报70.8美元,该股过去5个交易日跌0.38%,年初至今涨2.55%,过去60日跌8.8%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424094247a464a1ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424094247a464a1ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139","INSM"],"gpt_icon":0},{"id":"2529362877","title":"Insmed Incorporated4月21日成交额为1.41亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362877","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529362877?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:44","pubTimestamp":1745286254,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日,Insmed Incorporated成交额为1.41亿美元,成交额较昨日增加30.59%,当日成交量为202.65万股。Insmed Incorporated于2025年4月21日跌4.32%,报69.51美元,该股过去5个交易日涨1.37%,年初至今涨0.68%,过去60日跌10.7%。该公司还在开发Brensocatib,一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂,一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094418a6c316cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094418a6c316cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","INSM","BK4139","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2529077381","title":"Insmed Incorporated盘中异动 大幅跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529077381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529077381?lang=zh_cn&edition=full","pubTime":"2025-04-21 23:41","pubTimestamp":1745250107,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日23时41分,Insmed Incorporated股票出现异动,股价大幅下跌5.00%。Insmed Incorporated股票所在的生物技术行业中,整体跌幅为0.09%。其相关个股中,Dogwood Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Aptevo Therapeutics Inc.涨幅较大,Transcode Therapeutics, Inc.、Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为1686.11%、1222.67%、881.02%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Ocean Biomedical Inc C/Wts 14/02/2028 、Dogwood Therapeutics, Inc.,振幅分别为106.34%、100.53%、58.81%。Insmed Incorporated公司简介:Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421234147aa2c74b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421234147aa2c74b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","INSM","BK4139","LU0053671581.USD","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2528704043","title":"Insmed Incorporated4月17日成交额为1.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528704043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528704043?lang=zh_cn&edition=full","pubTime":"2025-04-18 09:44","pubTimestamp":1744940681,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日,Insmed Incorporated成交额为1.08亿美元,成交额较昨日增加0.64%,当日成交量为150.11万股。Insmed Incorporated于2025年4月17日涨3.49%,报72.65美元,该股过去5个交易日涨12.1%,年初至今涨5.23%,过去60日跌7.39%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-17|1.08亿|0.64%|150.11万|#|2025-04-16|1.07亿|-2.81%|152.95万|#|2025-04-15|1.10亿|-34.31%|156.29万|#|2025-04-14|1.68亿|36.48%|238.60万|#|2025-04-11|1.23亿|-41.49%|182.34万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418094450a45d43be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418094450a45d43be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","INSM","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2528368782","title":"Insmed Incorporated4月16日成交额为1.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528368782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528368782?lang=zh_cn&edition=full","pubTime":"2025-04-17 09:42","pubTimestamp":1744854146,"startTime":"0","endTime":"0","summary":"美东时间2025年4月16日,Insmed Incorporated成交额为1.07亿美元,成交额较昨日减少2.81%,当日成交量为152.95万股。Insmed Incorporated于2025年4月16日跌1.22%,报70.2美元,该股过去5个交易日涨3.92%,年初至今涨1.68%,过去60日跌8.53%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-16|1.07亿|-2.81%|152.95万|#|2025-04-15|1.10亿|-34.31%|156.29万|#|2025-04-14|1.68亿|36.48%|238.60万|#|2025-04-11|1.23亿|-41.49%|182.34万|#|2025-04-10|2.10亿|-36.56%|327.76万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417094235a6bd4327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417094235a6bd4327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0053671581.USD","LU0889565916.HKD","INSM","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2527086131","title":"Insmed Incorporated4月14日成交额为1.68亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527086131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527086131?lang=zh_cn&edition=full","pubTime":"2025-04-15 09:38","pubTimestamp":1744681101,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日,Insmed Incorporated成交额为1.68亿美元,成交额较昨日增加36.48%,当日成交量为238.60万股。Insmed Incorporated于2025年4月14日涨3.59%,报71.03美元,该股过去5个交易日涨4.32%,年初至今涨2.88%,过去60日跌2.36%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-14|1.68亿|36.48%|238.60万|#|2025-04-11|1.23亿|-41.49%|182.34万|#|2025-04-10|2.10亿|-36.56%|327.76万|#|2025-04-09|3.31亿|78.63%|507.17万|#|2025-04-08|1.86亿|-24.75%|282.51万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415093827a6baaa2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415093827a6baaa2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","LU0889565916.HKD","LU0320765992.SGD","INSM","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2526272756","title":"Insmed Incorporated4月11日成交额为1.23亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526272756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526272756?lang=zh_cn&edition=full","pubTime":"2025-04-12 09:40","pubTimestamp":1744422045,"startTime":"0","endTime":"0","summary":"美东时间2025年4月11日,Insmed Incorporated成交额为1.23亿美元,成交额较昨日减少41.49%,当日成交量为182.34万股。Insmed Incorporated于2025年4月11日涨5.8%,报68.57美元,该股过去5个交易日跌0.88%,年初至今跌0.68%,过去60日跌2.32%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-11|1.23亿|-41.49%|182.34万|#|2025-04-10|2.10亿|-36.56%|327.76万|#|2025-04-09|3.31亿|78.63%|507.17万|#|2025-04-08|1.86亿|-24.75%|282.51万|#|2025-04-07|2.47亿|13.40%|366.68万|Insmed Inc是一家生物制药公司,致力于改变患有严重和罕见疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412094053a6b8599a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412094053a6b8599a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0053671581.USD","INSM","BK4139","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2514113720","title":"Insmed(INSM.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价100.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514113720","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514113720?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:23","pubTimestamp":1740500610,"startTime":"0","endTime":"0","summary":"Insmed(INSM.US)获加拿大皇家银行首次覆盖,给予优于大市评级, 目标价100.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26002348385754.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2513875615","title":"Insmed Incorporated2024财年实现净利润-9.14亿美元,同比减少21.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513875615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513875615?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:00","pubTimestamp":1740326449,"startTime":"0","endTime":"0","summary":"2月24日,Insmed Incorporated公布财报,公告显示公司2024财年净利润为-9.14亿美元,同比减少21.87%;其中营业收入为3.64亿美元,同比增加19.34%,每股基本收益为-5.57美元。从资产负债表来看,Insmed Incorporated总负债17.40亿美元,其中短期债务16.50百万美元,资产负债比为1.17,流动比率为5.45。机构评级:截至2025年2月24日,当前有15家机构对Insmed Incorporated目标价做出预测,其中目标均价为96.93美元,其中最低目标价为89.00美元,最高目标价为108.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000118a250ce02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000118a250ce02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM"],"gpt_icon":0},{"id":"2513691213","title":"Truist Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由105.00美元调整至108.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513691213","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513691213?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:41","pubTimestamp":1740159669,"startTime":"0","endTime":"0","summary":"Truist Securities:维持Insmed(INSM.US)评级,由买入调整至买入评级, 目标价由105.00美元调整至108.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22014148321070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"1119035536","title":"异动解读 | 盘中狂泻5.11%!Insmed财报营收增长放缓、亏损扩大引发股价大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1119035536","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119035536?lang=zh_cn&edition=full","pubTime":"2025-02-20 22:37","pubTimestamp":1740062235,"startTime":"0","endTime":"0","summary":"在今日盘中交易中,生物制药公司Insmed股价大跌5.11%,引发了市场广泛关注。据分析,这与公司2024年第四季度财报表现不佳有很大关系。\n\n具体来看,Insmed上一季度销售额虽然达到1.0444亿美元、高于预期,但同比增长仅为24.79%,增速明显放缓。更为重要的是,Insmed当季每股亏损高达1.32美元,远高于分析师预期的1.17美元亏损。\n\n营收增长放缓加之亏损扩大,令投资者对Insmed的业务前景和盈利能力产生质疑,从而引发公司股价在盘中大幅下跌。Insmed面临着业绩增长乏力、成本控制不佳等一系列问题,当务之急是尽快扭转局面、实现盈利,从而重拾投资者信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSM"],"gpt_icon":0},{"id":"1148282852","title":"Insmed 2024年第四季度每股亏损$(1.32),低于$(1.17)的预期;销售额$1.0444亿,高于$1.0179亿的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1148282852","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148282852?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:09","pubTimestamp":1740053345,"startTime":"0","endTime":"0","summary":"Insmed 报告了季度每股亏损$,比分析师共识预期的$低了12.82%。这一亏损相比去年同期的每股亏损$减少了3.13%。公司报告的季度销售额为$1.0444亿,高于分析师共识预期的$1.0179亿,增长了2.60%。以上内容来自Benzinga Earnings专栏,原文如下:$Insmed$ reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 12.82 percent. This is a 3.13 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $104.44 million which beat the analyst consensus estimate of $101.79 million by 2.60 percent. This is a 24.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Insmed 2024年第四季度每股亏损$(1.32),低于$(1.17)的预期;销售额$1.0444亿,高于$1.0179亿的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INSM"],"gpt_icon":1},{"id":"2509774987","title":"小摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由83.00美元调整至92.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774987","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509774987?lang=zh_cn&edition=full","pubTime":"2025-02-08 05:21","pubTimestamp":1738963318,"startTime":"0","endTime":"0","summary":"小摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由83.00美元调整至92.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/08052148031920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2509274305","title":"大摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由85.00美元调整至90.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509274305","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509274305?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:22","pubTimestamp":1738851741,"startTime":"0","endTime":"0","summary":"大摩:维持Insmed(INSM.US)评级,由增持调整至增持评级, 目标价由85.00美元调整至90.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/06222248001920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INSM"],"gpt_icon":0},{"id":"2505205840","title":"Insmed Incorporated盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505205840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505205840?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:20","pubTimestamp":1737476447,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日00时20分,Insmed Incorporated股票出现异动,股价急速上涨5.09%。Insmed Incorporated股票所在的生物技术行业中,整体涨幅为1.61%。其相关个股中,Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大,Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃,换手率分别为757.13%、475.49%、182.30%,振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.,振幅分别为96.32%、41.33%、38.48%。Insmed Incorporated公司简介:Insmed Inc是一家全球性的生物制药公司,致力于改善严重和罕见疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122002047986e474b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122002047986e474b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","LU0889565916.HKD","INSM","LU0109394709.USD","LU0053671581.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insmed.com","stockEarnings":[{"period":"1week","weight":0.0169},{"period":"1month","weight":-0.0562},{"period":"3month","weight":-0.0562},{"period":"6month","weight":0.0539},{"period":"1year","weight":1.9126},{"period":"ytd","weight":0.0429}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insmed Incorporated是一家生物制药公司,专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法,证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果,安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.470588,"avgChangeRate":0.071463},{"month":2,"riseRate":0.411765,"avgChangeRate":0.079066},{"month":3,"riseRate":0.371429,"avgChangeRate":-0.053836},{"month":4,"riseRate":0.4,"avgChangeRate":0.04767},{"month":5,"riseRate":0.411765,"avgChangeRate":0.070481},{"month":6,"riseRate":0.529412,"avgChangeRate":0.014908},{"month":7,"riseRate":0.470588,"avgChangeRate":0.002456},{"month":8,"riseRate":0.382353,"avgChangeRate":-0.030186},{"month":9,"riseRate":0.558824,"avgChangeRate":0.031309},{"month":10,"riseRate":0.411765,"avgChangeRate":-0.025331},{"month":11,"riseRate":0.647059,"avgChangeRate":0.105304},{"month":12,"riseRate":0.470588,"avgChangeRate":0.046817}],"exchange":"NASDAQ","name":"Insmed","nameEN":"Insmed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Insmed,INSM,Insmed股票,Insmed股票老虎,Insmed股票老虎国际,Insmed行情,Insmed股票行情,Insmed股价,Insmed股市,Insmed股票价格,Insmed股票交易,Insmed股票购买,Insmed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}